NIH Testing Injectable Cabotegravir To Prevent HIV: Move Over, Truvada? Injectable cabotegravir is being tested by the NIH in an effort to develop other HIV prevention options. Currently, the oral tablet Truvada is the only HIV pre-exposure prophylaxis approved for use. by Dianne Depra